PMP · Question #1194
PMP Question #1194: Real Exam Question with Answer & Explanation
The correct answer is B: Complete development for the must-have functionalities only prior to demonstration in order to fail. For an innovative, disruptive product with market uncertainty and regulatory requirements, the appropriate development flow is to build only essential functionalities first, then demonstrate them quickly to test market acceptance and regulatory feasibility, embracing a 'fail fast
Question
A hybrid project has just started, which will result in a new technology that could disrupt the market if well accepted by the public. The product requires health and safety approvals from the government. As this is an innovative solution, the sponsor and product owner are unsure if it will be accepted by the public. What is the appropriate flow for product development?
Options
- AComplete development with all functionalities in perfect condition prior to demonstrating to
- BComplete development for the must-have functionalities only prior to demonstration in order to fail
- CComplete development for each sprint and demonstrate the product increment to internal
- DComplete development for must-have functionalities only and demonstrate it to a focus group, but
Explanation
For an innovative, disruptive product with market uncertainty and regulatory requirements, the appropriate development flow is to build only essential functionalities first, then demonstrate them quickly to test market acceptance and regulatory feasibility, embracing a 'fail fast' approach.
Common mistakes.
- A. Completing all functionalities before demonstration is a waterfall approach that risks significant investment in a product that might not be accepted by the market or approved by regulators.
- C. Demonstrating each sprint increment internally doesn't address the critical external validation needed for market acceptance and government approvals, especially for a disruptive product.
- D. While demonstrating to a focus group is part of the process, the emphasis on 'but not to a regulator' misses a critical early step for a product requiring health and safety approvals.
Concept tested. Minimum Viable Product (MVP) and fail-fast strategy
Reference. https://www.agilealliance.org/agile101/minimum-viable-product/
Topics
Community Discussion
No community discussion yet for this question.